EPISODE · Dec 14, 2023 · 5 MIN
564: Flavored Tobacco Bans and Pricing Strategies, Respiratory Disease Guidance
from Public Health Review Morning Edition · host ASTHO
Dr. Barbara Wallace, Director of the Division of Chronic Disease Prevention at the New York State Department of Health, discusses various strategies to curb tobacco use; Dr. Marcus Plescia, ASTHO Chief Medical Officer, worries that too many sick people could eventually overwhelm hospitals as flu and RSV are increasing; and Dr. Steven Stack, ASTHO President and Commissioner of the Kentucky Department for Public Health, says work is underway to make the drug that can reverse an opioid overdose available in more places. ASTHO Webpage: Tobacco and Nicotine Products – The Unwavering Public Health Crisis ASTHO Blog Article: From the Chief Medical Officer – Preventing Respiratory Disease Spread with Less Authority, More Influence Rhode Island Current News Article: States Strive to Get Opioid Overdose Drug to More People ASTHO Webpage: Legislative Alerts
What this episode covers
Dr. Barbara Wallace, Director of the Division of Chronic Disease Prevention at the New York State Department of Health, discusses various strategies to curb tobacco use; Dr. Marcus Plescia, ASTHO Chief Medical Officer, worries that too many sick people could eventually overwhelm hospitals as flu and RSV are increasing; and Dr. Steven Stack, ASTHO President and Commissioner of the Kentucky Department for Public Health, says work is underway to make the drug that can reverse an opioid overdose available in more places. ASTHO Webpage: Tobacco and Nicotine Products – The Unwavering Public Health Crisis ASTHO Blog Article: From the Chief Medical Officer – Preventing Respiratory Disease Spread with Less Authority, More Influence Rhode Island Current News Article: States Strive to Get Opioid Overdose Drug to More People ASTHO Webpage: Legislative Alerts
NOW PLAYING
564: Flavored Tobacco Bans and Pricing Strategies, Respiratory Disease Guidance
No transcript for this episode yet
Similar Episodes
Apr 21, 2026 ·13m
Apr 19, 2026 ·16m
Apr 17, 2026 ·13m
Apr 13, 2026 ·11m
Apr 11, 2026 ·16m